Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Teva
Daiichi Sankyo
UBS
Harvard Business School
Express Scripts
Federal Trade Commission
Healthtrust
Citi

Generated: October 17, 2017

DrugPatentWatch Database Preview

INJECTAFER Drug Profile

« Back to Dashboard

What is the patent landscape for Injectafer, and what generic Injectafer alternatives are available?

Injectafer is a drug marketed by Luitpold Pharms Inc and is included in one NDA. There are four patents protecting this drug.

This drug has sixty-five patent family members in thirty countries.

The generic ingredient in INJECTAFER is ferric carboxymaltose. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ferric carboxymaltose profile page.

Summary for Tradename: INJECTAFER

US Patents:4
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list13
Drug Prices:see details
DailyMed Link:INJECTAFER at DailyMed

Pharmacology for Tradename: INJECTAFER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: INJECTAFER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,431,549Methods and compositions for administration of iron► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: INJECTAFER

Country Document Number Estimated Expiration
Cyprus1112680► Subscribe
Australia2003278111► Subscribe
European Patent Office1554315► Subscribe
Peru05712004► Subscribe
Norway335770► Subscribe
South Korea20080082674► Subscribe
South Korea20140117678► Subscribe
TaiwanI265028► Subscribe
Austria507246► Subscribe
European Patent Office1973549► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cerilliant
Cantor Fitzgerald
Baxter
Medtronic
Chinese Patent Office
Merck
Accenture
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot